These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 23865431)
21. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus. Clemons NJ; Wang DH; Croagh D; Tikoo A; Fennell CM; Murone C; Scott AM; Watkins DN; Phillips WA Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(12):G1335-46. PubMed ID: 23064761 [TBL] [Abstract][Full Text] [Related]
22. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829 [TBL] [Abstract][Full Text] [Related]
23. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study. Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571 [TBL] [Abstract][Full Text] [Related]
24. Management of Barrett's esophagus free of dysplasia. DeMeester SR Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346 [TBL] [Abstract][Full Text] [Related]
25. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Phillips RW; Frierson HF; Moskaluk CA Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477 [TBL] [Abstract][Full Text] [Related]
26. [Histochemical diagnosis of short segment Barrett's esophagus]. Fujiyama Y; Ishizuka I; Koyama S Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus. Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310 [TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717 [TBL] [Abstract][Full Text] [Related]
29. Barrett esophagus: history, definition and etiopathogeny. Gindea C; Birla R; Hoara P; Caragui A; Constantinoiu S J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):23-30. PubMed ID: 25870690 [TBL] [Abstract][Full Text] [Related]
30. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma. Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392 [TBL] [Abstract][Full Text] [Related]
31. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
32. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential. Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290 [TBL] [Abstract][Full Text] [Related]
34. Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus. Lee Y; Urbanska AM; Hayakawa Y; Wang H; Au AS; Luna AM; Chang W; Jin G; Bhagat G; Abrams JA; Friedman RA; Varro A; Wang KK; Boyce M; Rustgi AK; Sepulveda AR; Quante M; Wang TC Oncotarget; 2017 Jan; 8(1):203-214. PubMed ID: 27448962 [TBL] [Abstract][Full Text] [Related]
35. Cox2 and β-catenin/T-cell factor signaling intestinalize human esophageal keratinocytes when cultured under organotypic conditions. Kong J; Crissey MA; Stairs DB; Sepulveda AR; Lynch JP Neoplasia; 2011 Sep; 13(9):792-805. PubMed ID: 21969813 [TBL] [Abstract][Full Text] [Related]
36. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844 [TBL] [Abstract][Full Text] [Related]
37. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
39. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma. Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870 [TBL] [Abstract][Full Text] [Related]